Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch

Date: 01/19/2022

Product type: Drugs, Mislabeling

Company Announcement Date: January 18, 2022
FDA Publish Date: January 19, 2022
Product Type: Drugs
Reason for Announcement: Missing Label
Company Name: Mylan Pharmaceutical Inc.
Brand Name: Semglee
Product Description: Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens